BioMalaysia is Malaysia’s premier and largest biotechnology conference and exhibition since 2005.

Now, in a time of challenges and change, BioMalaysia 2009 is set to provide a strategic platform for fresh ideas, practical solutions and effective collaborations for global and Malaysian biotechnology industry participants.

In 2008, BioMalaysia set a new record with over 7,800 participants including 40 biotechnology experts from 30 countries speaking at the conference, 1,100 conference participants, 100 international and local exhibitors.

In 2009, BioMalaysia is set to exceed its success in 2008 in offering problem solving opportunities and partnerships in the commercialization of biotechnology.

Accelerating Commercialization in Biotechnology

BioMalaysia 2009 provides access to one of the most exciting biotechnology hubs in Asia – Malaysia. The Malaysian biotechnology industry is on track to accelerate commercialization in biotechnology by 2011 – supported by the National Biotechnology Policy and BiotechCorp, the leading biotechnology development agency.

To date, BiotechCorp has nurtured a network of 101 companies in agriculture, healthcare and industrial biotechnology under the BioNexus status. Of the 101 BioNexus companies, 30 have investments from Britain, France, Germany, Italy, Belgium, the US, India, China, Japan, Taiwan, Hong Kong, Singapore, Thailand, Australia and New Zealand.

Malaysia is also rapidly developing as the biotechnology investment hub for the US, Europe, GCC, ASEAN, India, China, Japan and Korea through the biotechnology designate sectors in the economic zones of Iskandar Development Region, Northern Corridor Economic Region, Eastern Corridor Economic Region, Sabah Development Corridor and the Sarawak Corridor of Renewable Energy.